Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs SP for Malaria Prophylaxis in Pregnancy
NCT03944317Phase 3Unknown
- Sponsor
- Federal Medical Centre, Owo
- Start
- Jun 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azithromycin in malaria (2 arms), sponsored by Federal Medical Centre, Owo. Primary endpoint: Malaria parasitaemia during pregnancy. Status: unknown.
02
Drugs
azithromycin
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03944317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03944317.